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Abstract
Background: The head and neck are two of the most common sites of extranodal non-Hodgkin's
lymphoma (NHL). However, primary tumors of the infratemporal fossa are infrequent, and NHL
in this region is extremely rare.
Case presentation: We present a case of a 41-year-old female that presented with swelling in
the right preauricular region that had persisted for the past two years. The patient was diagnosed
as having a small lymphocytic NHL. She initially underwent chemo-radiation but reported relapse.
The tumor was excised and again the patient underwent chemotherapy. The patient remained
symptomatic and developed a second primary squamous cell carcinoma in the right retromolar
trigone.
Discussion and conclusion: We discussed NHL with an emphasis on extranodal manifestations.
Extranodal NHL that is limited to a single site can be managed by surgery and regular follow up. To
the best of our knowledge, this is only the second case of primary NHL of the infratemporal fossa
to be reported in the literature.
Background
The head and neck are some of the most common sites of
extranodal non-Hodgkin's lymphoma [1], with Wal-
deyer's ring being the most common site of manifestation
within the region. The oral cavity, salivary glands, thyroid
gland, paranasal sinuses, nasal cavity, parapharyngeal
space, larynx, and infratemporal fossa are the other sites in
which NHL may occur in the region [1-9]. However, pri-
mary tumors of the infratemporal fossa are infrequent,
and NHL in this region is extremely rare [5-10]. In this
report, we present a new case of extranodal NHL arising in
the infratemporal fossa, the second such case to be
reported in the literature. We reviewed the literature on
non-Hodgkin lymphoma with a special emphasis on
extranodal manifestations.
Case presentation
In July 2006, a 41-year-old female presented with a swell-
ing in the right preauricular region, which had persisted
for the past two years, and was having difficulty opening
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insidious in onset and progressive. In the first six months,
the patient indicated the swelling was painless, only later
becoming painful as the size increased.
Local examination found a diffuse 5 × 4 cm firm to cystic
mass with restricted mobility in the right preauricular
region. Examination of the oral cavity, ear, cranial nerves,
and other systems was unremarkable. MRI analysis indi-
cated a large mass in the right infratemporal fossa with
significant infiltration into the adjoining muscles. This
mass was hypo-isointense on T1 (Fig 1A–C) and heteroge-
neously hyperintense on T2 weighted images (Fig 2A–C).
The mass had significant enhancement in post-contrast
MRI (Fig 3A–D). Hematological and biochemistry analy-
ses were normal. Fine needle aspiration cytology (FNAC)
(Fig. 4) revealed a monotonous population of small,
round lymphoid cells with regular nuclei, compact chro-
matin, inconspicuous nucleoli, and scant basophilic cyto-
plasm. These findings were consistent with NHL.
Diagnostic biopsy (Fig. 5A &5B) of the tissue confirmed
small lymphocytic non-Hodgkin's lymphoma. The
patient was investigated further to determine the staging
of the NHL, but no lymph node or other organ was found
to be involved. The patient was scheduled for chemo-radi-
ation treatment and given nine cycles of the CHOP regime
(cyclophosphamide, doxarubicine, vicristine, and pred-
nisolone) and a total of 55G radiation in 25 fractions over
five weeks. The patient remained asymptomatic for seven
months.
In Nov 2007, the patient again presented with similar
symptoms. A computed axial tomography (CT) scan (Fig.
6A–C) revealed a hypodense mass of 37 Hounsefield unit
(HU) density and measuring 4.25 cm × 4.0 cm in the right
temporal and infratemporal region. Post-contrast, this
mass showed heterogeneous enhancement (66 HU den-
sity) and normal contents (muscles) were not identifiable
from the mass. The tumor was excised and histopathology
again confirmed the diagnosis of NHL. The patient was
given six cycles of ifosfamide, metoxantron, and etopo-
side, with the last cycle on June 3rd, 2008. The patient was
on regular follow up, and in Aug 2008 presented with
increasing trismus. On examination, the infratemporal
A-C: MRI (axial sections) showing a big hypo-isointense mass in the right temporal and infratemporal fossa on T1 weighted imagesFigure 1
A-C: MRI (axial sections) showing a big hypo-isointense mass in the right temporal and infratemporal fossa on 
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the right retromolar area (Fig 7). A punch biopsy of the
ulcer found it to be a well-differentiated squamous cell
carcinoma. The patient was advised to undergo surgery for
this carcinoma, but she did not come in for further follow
up.
Discussion
The gastrointestinal tract, followed by the head and neck,
is the most common site of extranodal NHL [9], with the
head and neck contributing to about 11% to 33% of total
cases [11,12]. However, NHL is very rare in the superficial
tissues of the head and neck region [8].
NHL is predominantly found in males of Caucasian
descent [1,2,9,13]. Other risk factors [1,2,9,13-17] for the
development of NHL include inherited and acquired
immunodeficiency diseases, EBV, H. pylori and HTLV-I
infections, chromosomal abnormalities, drug induced
immunocompromised states, autoimmune diseases (e.g.,
rheumatoid arthritis and Sjogren's disease), exposure to
pesticides and radiation, phenytoin therapy, previous his-
tory of Hodgkin's disease or chemotherapy, and excessive
intake of meat and fat.
Extranodal NHL may present as a painless and progres-
sively expanding lump or a widespread disease. The
patient may be without any systemic symptoms ('A' symp-
toms) or may have night sweating, fever, and/or weight
loss of greater than 10% of total body weight, which con-
stitutes 'B' symptoms. FNAC gives a clear diagnosis of lym-
phoma and an uncrushed biopsy should be performed to
ensure the accurate histological grading of the lymphoma
[9].
In the head and neck, diffuse lymphoma (intermediate-
grade) predominates, with diffuse large-cell lymphoma
being the most common histological type of NHL [1,2,9].
B cells comprise the most common NHL of the head and
neck, although T-cell lymphoma is common in the nasal
cavity and nasopharynx [18,19].
The accurate staging of extranodal NHL is important for
effective planning of the treatment approach [2]. Staging
A-C: This mass is heterogeneously hyper-intense on T2 weighted images (axial sections) of MRFigure 2
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A-D: The mass is showing significant enhancement in post-contrast MR images (axial and coronal sections)Figure 3
A-D: The mass is showing significant enhancement in post-contrast MR images (axial and coronal sections).
Microphotograph of FNAC showing small, round lymphoid cells with re ular nuclei, compact chromatin, inconspicu us nu leoli, and sc nt basophilic cytopla  (marked‘1’) sugges-tive f NHLFigure 4
Microphotograph of FNAC showing small, round 
lymphoid cells with regular nuclei, compact chroma-
tin, inconspicuous nucleoli, and scant basophilic cyto-
plasm (marked‘1’) suggestive of NHL. (MGG × 400).
A-B: Microphotograph of small lymphocytic NHL with infil-tration into infratemporal fossa and showing hyalinised fibrous band (M rked '1') and small, r und lymphoid cells with regular uclei, compact chro atin, in ons icuous ucle-ol , and sc nt basophilic cyt p sm (marked '2')Figu 5
A-B: Microphotograph of small lymphocytic NHL 
with infiltration into infratemporal fossa and showing 
hyalinised fibrous band (Marked '1') and small, round 
lymphoid cells with regular nuclei, compact chroma-
tin, inconspicuous nucleoli, and scant basophilic cyto-
plasm (marked '2'). (Fig 5A: H & E × 100; Fig 5B: H & E 
400).
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and radiological investigations. Conley et al. [2] found
nodal disease in 50% of all cases at the time of presenta-
tion or during management, and they advised a detailed
work up of all patients. It is further recommended that all
cases of NHL should undergo a complete evaluation
[1,8,9,13-17], including a complete hemogram, liver and
renal functions, serum 2-microglobulions, chest X-ray,
bone marrow biopsy, gallium scan, and cerebrospinal
fluid analysis, as well as CT scans of the abdomen, pelvis,
and bones. As a majority of our patients are low-income,
initially we undertake ultrasonography of the abdomen
and X-rays of the pelvis, vertebra, and femurs. Then, if
required, a CT is performed in suspicious cases.
The Ann Arbor staging system classifies lymphoma in four
stages (I-IV) with 'A' and 'B' symptoms and the recently
added 'E' sub stage [15,17] for localized, solitary involve-
ment of extra-lymphatic tissue, excluding the liver and
bone marrow.
The treatment of NHL is a controversial issue [1,9,13-
17,20]. It consists of chemotherapy, radiotherapy, or sur-
gery. Sometimes, in cases of limited extranodal NHL, only
surgery without chemotherapy or radiotherapy is used
[17]. However, the main role of surgery is diagnostic only
and rarely used for a cure [8], as in our case. In contrast,
combined modalities, including surgery, chemotherapy,
or radiotherapy, are used to treat advance NHL [13-17]. In
stage I and II low grade extranodal lymphomas of the
head and neck, radiotherapy is the first line of treatment,
although the use of chemotherapy has also been advo-
cated [1,9,13-17,20]. Chemotherapy is the standard treat-
ment for intermediate grade lymphomas [13-17,20]. The
addition of an anti-CD20 monoclonal antibody (rituxi-
mab) in the CHOP regimen (R-CHOP) has demonstrated
promising results and is now frequently used for treat-
ment of lymphomas. A total of 3–4 cycles of this regimen
followed by radiotherapy are quite effective in the treat-
ment of stage I and non-bulky stage II NHL; however,
bulky stage II-IV tumors need 6–8 cycles of this chemo-
A-C: CT scan (axial section) showing hypodense (37 HU) mass in the right temporal and infratemporal region (Fig. 6A)Figure 6
A-C: CT scan (axial section) showing hypodense (37 HU) mass in the right temporal and infratemporal region 
(Fig. 6A). The mass had heterogeneous enhancement (66 HU) in contrast CT scan (axial and coronal sections) (Fig 6B-C). 
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ifosfamide, and mitoxantrone are other chemotherapeu-
tic agents used to treat NHL [17,20]. Advance stage and
high grade NHL warrants aggressive chemotherapy and
treatment is generally palliative. Autologous bone mar-
row transplantation is the treatment of choice for recur-
rent NHL that is still sensitive to chemotherapy. The use
of radiolabeled, monoclonal antibodies (e.g., ibritu-
momab tiuxetan and tositumomab) and interferon have
also been advocated, but clinical use is still limited [13-
17,21].
Prognosis is calculated according to the International Prog-
nostic Index (IPI) for patients at or above the age of 60
years. It is calculated based on age, LDH levels, perform-
ance status, and the number of extranodal sites involved.
Factors such as molecular features of the tumor, levels of
cytokines and soluble receptors, and surrogate markers
have also been implicated in accurate prognosis, but these
are clinically still under investigation [15]. The prognosis
declines with an increase in the patient's age, LDH levels,
histological grade, or stage of the NHL. According to the
IPI, the 5-year survival for all ages is about 73%–83% for
low grade, 51%–69% for low-intermediate, 43%–46% for
high-intermediate, and 26%–32% for high-grade NHL
[17]. Shima et al. [1] found decreased (28%) 5-years sur-
vival rates in young patients (≤ 20-years-old) irrespective of
the stage of extranodal NHL.
A primary NHL of the infratemporal region is a rare clini-
cal entity, and we found only one previous report of iso-
lated NHL of the temporal region [8]. This report
documented a 65-years-old female with painless temporal
swelling. A complete excision was performed and the
patient had no recurrence, even in the absence of chemo-
or radiotherapy.
Conclusion
This is the second case of primary NHL of the infratempo-
ral fossa to be reported in the literature. The case discussed
in this report was of clinical importance, as the patient
had localized isolated primary NHL of the temporal
region that was excised after failed chemoradiation. Histo-
logical examination found small lymphocytic-type NHL,
which is infrequent in the head and neck region [1,2]. The
patient had a complete recovery but subsequently pre-
sented with radiation-induced second primary squamous
cell carcinoma. Limited extranodal NHL can be managed
by surgery alone, and radiotherapy has only a limited effi-
cacy and potential side effects, including the induction of
a second primary tumor.
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